Experimental cancer drug trial halted early
Disease control
Terminated
This early-stage trial tested a new oral drug, BBI-825, in 19 people with advanced solid tumors that had stopped responding to standard treatments. The goal was to find a safe dose and see if the drug could help control the cancer when used alone or with other targeted therapies.…
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated May 11, 2026 20:52 UTC